Company news
Wockhardt Limited (NSE:WOCKPHARMA) news
Wockhardt Limited news releases on 6ix. Latest, May 26, 2023: Press Release May 26 2023
Press releases — page 2
Press Release May 26 2023
May 26, 2023
Press Release Aug 16 2022
August 16, 2022
Press Release Mar 20 2022
March 20, 2022
Press Release Mar 16 2022
March 16, 2022
Press Release Feb 08 2022
February 8, 2022
Press Release Jan 27 2022
January 27, 2022
Press Release Nov 08 2021
November 8, 2021
Press Release Aug 26 2021
August 26, 2021
Press Release Aug 13 2021
August 13, 2021
Press Release Jul 27 2021
July 27, 2021
Press Release Jul 22 2021
July 22, 2021
Press Release Jul 05 2021
July 5, 2021
Press Release May 27 2021
May 27, 2021
Press Release Feb 10 2021
February 10, 2021
Press Release Jan 29 2021
January 29, 2021
Press Release Dec 01 2020
December 1, 2020
Press Release Nov 02 2020
November 2, 2020
Press Release Aug 31 2020
August 31, 2020
Press Release Aug 29 2020
August 29, 2020
Press Release Aug 03 2020
August 3, 2020
Wockhardt : receives US FDA Qualified Infectious Disease Product designation for WCK 6777, a first ever once-a-day -lactam enhancer class antibiotic
April 21, 2020
Wockhardt : receives ANDA approval for pain medication Oxycodone liquid
June 29, 2015
Wockhardt Limited : Wockhardt launches generic version of anti-convulsant drug Lamictal XR
January 8, 2013
Wockhardt Limited : Wockhardt receives US FDA approval for generic version of Parkinsonism drug Requip XL®
August 28, 2012